TP53 Signature Score Predicts Prognosis and Immune Response in Triple-negative Breast Cancer. Onishi M, Yamaguchi S, Wen X, Han M, et al. Anticancer Res 2023;43:1731-1739.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Onishi M, Yamaguchi S, Wen X, Han M, et al. TP53 Signature Score Predicts Prognosis and Immune Response in Triple-negative Breast Cancer. Anticancer Res 2023;43:1731-1739.
PMID: 36974826